Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/44146, first published .
Acceptance and Commitment Therapy Wellness Program for Latine Adults Who Smoke and Have Psychological Distress: Protocol for a Feasibility Study

Acceptance and Commitment Therapy Wellness Program for Latine Adults Who Smoke and Have Psychological Distress: Protocol for a Feasibility Study

Acceptance and Commitment Therapy Wellness Program for Latine Adults Who Smoke and Have Psychological Distress: Protocol for a Feasibility Study

Original Paper

1Department of Psychological, Health, & Learning Sciences, University of Houston, Houston, TX, United States

2Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX, United States

3Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, United States

4Behavioral Sciences Research Institute, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico

5Huntsman Cancer Institute and the Department of Population Health Sciences, University of Utah, Salt Lake City, UT, United States

Corresponding Author:

Virmarie Correa-Fernández, PhD

Department of Psychological, Health, & Learning Sciences

University of Houston

3657 Cullen Blvd. #491 (Farish Hall)

Houston, TX, 77204

United States

Phone: 1 7137430334

Email: vcorreaf@central.uh.edu


Background: Tobacco smoking is a major independent risk factor for chronic disease, and the prevalence of smoking among people with behavioral health disorders is 2-fold in comparison with the general population. Smoking rates remain high for various subgroups within the Latine community, the largest ethnic minority group in the United States. Acceptance and commitment therapy (ACT) is a theoretically sound and clinically validated therapeutic approach for several behavioral health conditions with growing evidence of its effectiveness for smoking cessation. Unfortunately, the evidence of ACT effectiveness for smoking cessation among Latine individuals is scarce, and none of the existing studies have tested a culturally targeted intervention for this population.

Objective: This study aims to address the co-occurrence of smoking and mood-related challenges among Latine adults via the development and testing of a culturally tailored ACT-based wellness program: Project PRESENT.

Methods: This study entails 2 phases. Phase 1 consists of the intervention development. Phase 2 entails the pilot testing of the behavioral intervention along with the administration of baseline and follow-up measures to 38 participants. Primary outcomes include feasibility of recruitment and retention, and treatment acceptability. Secondary outcomes are smoking status and depression and anxiety scores at end of treatment and 1-month follow-up.

Results: This study received institutional review board approval. Phase 1 outputs were the health counselors’ treatment manual and participant guide. Recruitment was completed in 2021. Phase 2 outcomes will be determined after project implementation and data analyses are complete, which are expected by May 2023.

Conclusions: Findings from this study will determine the feasibility and acceptability of an ACT-based, culturally relevant intervention for Latine adults who smoke and have probable depression and/or anxiety. We expect feasibility of recruitment, retention and treatment acceptability, and reductions in smoking status, depression, and anxiety. If feasible and acceptable, the study will inform large-scale trials, which will ultimately contribute to narrowing the gap between research and clinical practice for the co-occurrence of smoking and psychological distress among Latine adults.

International Registered Report Identifier (IRRID): DERR1-10.2196/44146

JMIR Res Protoc 2023;12:e44146

doi:10.2196/44146

Keywords



Tobacco smoking is a major independent risk factor for chronic disease [1,2]. Although the number of smokers in the United States has declined over the past decades, smoking prevalence remains disproportionately high among individuals with behavioral health disorders [3-5]. For instance, depressive and anxiety syndromes are more prevalent among smokers than nonsmokers [6,7], and smokers with these conditions are more likely to be nicotine dependent [4,8]. Considerable research has assessed the impact of depression and anxiety on cessation outcomes, with a number of studies reporting that depression and anxiety place smokers at increased risk for cessation failure [9-14], with other studies suggesting that the evidence is inconclusive [6,15-18]. Additionally, given the high comorbidity between depression and anxiety [19], the independent contribution of each disorder to smoking cessation remains unclear [11,20,21]. The Treating Tobacco Use and Dependence Clinical Practice Guideline: 2008 Update concluded that the evidence is insufficient to determine whether smokers with psychiatric disorders benefit more from tobacco use treatment tailored to their disorder than from standard treatments [22].

Given the link between behavioral health issues and smoking, it would be ideal to identify an intervention that might be especially appropriate for people with behavioral health issues who smoke. Acceptance and Commitment Therapy (ACT) belongs to what is known as “third wave” cognitive behavioral therapy and is positioned as a form of “contextual cognitive behavioral therapy” [23]. An important and unique assumption underlying ACT’s treatment approach is that, through conditioning processes, humans learn to avoid thoughts and their accompanying feelings, images, and physical sensations as they would avoid the event itself [24]. This avoidance of aversive private events, called experiential avoidance, is assumed to underlie much of people’s suffering, and emotional dysregulation arises from attempts to avoid and alter private experiences that are judged to be aversive [25].

Unfortunately, experiential avoidance often results in an increase in the frequency or intensity of the avoided thoughts and feelings [26] and can generate mood disturbances, including depression and anxiety. An important component of ACT is helping individuals abandon efforts to change their thoughts and feelings and instead engage in an active process of experiencing emotions simply as a constellation of physiological sensations, which have no intrinsic power to harm or hold one back. The goal is the removal of experiential avoidance as a barrier to pursuing valued outcomes (ie, quitting smoking and improving mood).

With respect to substance abuse, behaviors like tobacco smoking are often negatively reinforced via attempts to regulate and control internal, negative experiences [27]. In ACT-based models for the treatment of tobacco use disorders [28], individuals are helped to identify subtle signals of negative affect and to understand that efforts to control or avoid internal experiences are linked to their tobacco use behavior. They are then taught to develop acceptance and willingness to remain in the presence of withdrawal symptoms and aversive internal states associated with triggers to smoke tobacco.

ACT has increasingly shown its effectiveness for treating smoking, depression, and anxiety [23,29-31], and its applicability to diverse populations [32]. However, research on the usefulness of ACT approaches for Hispanic or Latine (hereafter Latine, a gender-neutral term) populations, the largest ethnic minority group in the United States [33,34], is limited. Although there are some ACT-related studies that include a considerable proportion of Latine people in their samples [29,35], there is only 1 published study specifically focused on Latine individuals in the United States [36]. However, this study is a secondary data analyses of treatment engagement and efficacy from an ACT treatment not culturally tailored to the population. Moreover, no published studies have specifically addressed smoking cessation among Latine individuals with depressive and anxiety symptomatology.

These gaps in the literature illustrate the need for an ACT smoking cessation treatment that is appropriate for Latine individuals with behavioral health issues. ACT represents a coherent theoretical framework from which to address many of the factors that may present barriers to smoking cessation among Latine individuals with depression and anxiety symptomatology. Hence, the proposed study (ie, PRESENT Wellness Program) aims to improve the health of the Latine community by developing and pilot-testing a culturally relevant ACT-based wellness program addressing smoking, depression, and anxiety among Latine adults.


Phase 1: Intervention Development: The PRESENT Wellness Program

The PRESENT Wellness Program consists of the ACT-based behavioral treatment component with a participant’s guide and nicotine replacement therapy (NRT).

Behavioral Treatment Component and Participant Guide

The techniques used in ACT target the following six main processes [37]: (1) acceptance—willingness to experience the natural flow of thoughts, feelings, and sensations (not trying to suppress them); (2) cognitive defusion—ability to recognize thoughts and images as just words and pictures, not as real events; (3) beingpresent—focus on the present in a nonjudgmental way; (4) self-as context—exposure to experiential processes to promote awareness of one’s own flow of experiences without attachment to them; (5) values—awareness and clarification of personal values and goals; and (6) committed action—willingness to behave in line with values and goals, even in the presence of discomfort.

The baseline behavioral treatment was developed using an ACT-based smoking cessation protocol described in existing publications on ACT and smoking cessation [38-40]. This baseline treatment protocol was then adapted to also address depression and anxiety and to be culturally appropriate for Latine adults. The behavioral health and cultural adaptations were informed by an existing framework for adaptation [41,42], the first author’s training on the ACT therapeutic model, and expert consultation. A literature review informed changes to content and to the frequency and duration of sessions.

Adaptations of the baseline protocol to address co-occurring depression and anxiety entailed the proactive inclusion of emotional dysregulation discussions and experiences as part of the treatment. Regardless of participants’ initiative to share their experiences with mood management, the health counselor proactively inquires about the person’s psychological distress, validates their pain, and highlights that facing discomfort is an inevitable human experience oftentimes necessary for valued living. ACT works to enhance an individual’s ability and willingness to experience undesirable or adverse thoughts and feelings, which is expected to assist individuals in developing broader alternatives to mood management. Adaptations of the baseline protocol to be culturally appropriate for Latine individuals started with the labeling of the treatment. For instance, given Latine individuals’ stigma related to seeking behavioral health help [43], we chose to call the treatment a “wellness program” so it could be better received by the Latine community. Similarly, we use the terms “health counselor” and “health counseling” to refer to the therapist and the treatment sessions, respectively, to increase openness to the program. Adaptations were also based on the ideas of cross-cultural communication [44,45] as well as the integration of Latine values (eg, familism, personalism, and collectivism) and context (eg, heritage group, acculturation, and enculturation) [46].

The treatment manual includes overall training modules that cover the ACT model, tobacco dependence, depression, anxiety, Latine cultural values, and a session-by-session guideline that includes the core aspects of ACT and their applications for treatment of tobacco dependence and depression or anxiety. The participant’s guide mirrored the counselors’ treatment manual content in a more simplified manner and includes practice exercises.

The treatment protocol consists of 8 one-hour individual sessions. Session 1 entails the contextual interview (focused on smoking and psychological distress) and offers didactic information about the effectiveness and use of NRT. The contextual interview is organized around valued domains of living (ie, relationships, health, work, education, and leisure) and the functionality of smoking. Sessions 2-7 focus on each one of the 6 core ACT processes [23,37]. Session 2 focuses on clarifying participants’ overall values and those involved in quitting smoking, as well as the discrepancies between current behaviors and values. Session 3 focuses on discussing and demonstrating what SMART goals are (ie, specific, meaningful, adaptive, realistic, and timebound) and the development of a preliminary plan to stop smoking, including setting a quit date. Session 4 introduces participants to mindfulness and helps them notice their internal and external triggers as they occur and to recognize the link between connecting with emotions and the ability to act on them. Session 5 aims to increase participants’ willingness to accept cravings and withdrawal symptoms as a typical experience of the quitting process and develop motivation and skills to deal with them without smoking. Session 6 helps participants identify and defuse (or to get “unhooked”) from thoughts that limit their achievement of quitting smoking and mood-related behavioral goals. In this context, defusion is to see thoughts simply as thoughts rather than as a literal truth that can control one’s behavior. Session 7 guides participants to connect with a transcendent sense of self that is separate from their own internal experience but provides a safe place to observe them. Session 8 focuses on overall experiences during the wellness program as well as the creation of an individual self-care plan for the future, including value-based actions. All sessions include experiential exercises and metaphors tailored to the participant’s situation. Latine-specific issues are incorporated into each session. Participants are instructed to engage in value-based actions as homework assignments between sessions. Table 1 below shows a summary of the session-by-session content with focal exercises [47].

Table 1. Summary of session-by-session content.
SessionOverview of the sessionExperiential exercise
1Contextual interview, explanation of the ACTa model and overall wellness program, and didactic information about NRTbLife path
2Values identificationBull’s eye
3Goal setting and committed action (quit day is encouraged)Establishing SMARTc goals
4Contact with the present momentMindful breathing
5Acceptance and willingnessThe ball in the pool metaphor
6Cognitive defusion (getting unhooked!)Hands as thoughts metaphor
7Self as context (also called perspective taking)The stage show metaphor
8Integration and maintenanceMiracle question and Passenger on the bus metaphor

aACT: acceptance and commitment therapy.

bNRT: nicotine replacement therapy.

cSMART: specific, meaningful, adaptive, realistic, and timebound.

Health counselors with at least a master level degree in clinical or counseling psychology are trained to provide the PRESENT Wellness Program. Specifically, the health counselors undergo about 100 hours of specialized training in tobacco dependence treatment and ACT, including didactic, experiential, and applied training. Before engaging with study participants, health counselors role-play the treatment sessions and have to demonstrate ACT competency, measured by the ACT Core Competency Rating Form [37].

Guideline for NRT Use

NRT is offered as part of the PRESENT Wellness Program. The selected NRT is the nicotine patch because it is frontline therapy for smoking cessation, is safe, well-tolerated, and available over the counter [22]. Also, the nicotine patch has proven effective among smokers with depression and anxiety symptomatology [48]. Participants are given 6 weeks of nicotine patches and are told to start using them 1 week before the quit day, which is encouraged on Session 3. Participants smoking more than 10 cigarettes per day are given 4 weeks of 21-mg patches, 1 week of 14-mg patches, and 1 week of 7-mg patches. Participants who smoke 5-10 cigarettes per day are given 4 weeks of 14 mg patches and 2 weeks of 7 mg patches.

Phase 2: Pilot Testing: Study Design and Participants

This is a longitudinal, 1-arm pre-post feasibility study. A total of 38 participants will be enrolled in the study. The inclusion criteria are ≥18 years of age; self-identify as Latine (of any national group); current smoker (average of >5 cigarettes per day for the past year and carbon monoxide [CO] >6 ppm); motivated to quit within next 30 days; screened positive for probable depression and/or probable anxiety (via a score of >10 in the Patient Health Questionnaire [49-51]; at least marginal health literacy; functioning telephone number; ability to speak English; and physicians’ release to participate if taking psychotropic medications. Of note, we chose to recruit only English-speaking Latine participants because it facilitates the supervision of sessions and preparation of materials in only 1 language, maximizing the feasibility of completing the study within the time frame and available resources. The exclusion criteria are contraindication for use of nicotine patch; current use of tobacco cessation medications; current participation in counseling for depression, anxiety, or smoking cessation; being pregnant or nursing; having other current psychiatric disorder that would limit ability to participate; and having a household member enrolled in the study.

Procedures

Recruitment and Screening

Participants are mainly recruited through community outreach, social and print media (eg, local newspaper), flyers, and the ResearchMatch platform [52]. To determine eligibility criteria, interested people complete a phone screening with project staff or complete a self-screening accessed via a QR code located in the study flyer. Individuals who are ineligible or decline participation are given self-help materials and referrals to other cessation programs. Eligible individuals are scheduled for their first appointment.

Baseline Visit

During the in-person baseline visit, study personnel provide a detailed description of the study, answer questions, and obtain informed consent. Enrolled participants complete web-based baseline questionnaires, biochemical verification of smoking status (via a CO test), and their first health counseling session.

Treatment Procedures and Fidelity

The health counseling component consists of 8 one-hour individual sessions (1 in person and 7 by phone) completed within a 3-month period. The initial 2-week nicotine patch is dispensed at the first face-to-face visit and then sent biweekly by regular mail. Participants receive only the number of patches necessary to last 2 weeks, plus several extra patches should a patch fall off or become torn.

Treatment fidelity refers to the extent to which an intervention is delivered as planned. To ensure treatment fidelity, all sessions are recorded and a random sample of at least 15% are coded using the following two forms: (1) an investigator-developed checklist to track fidelity to treatment content per session and (2) the ACT Core Competency Rating Form to determine adherence to an ACT therapeutic approach [37]. The checklist entails a list of all session components (per session), which are marked as covered or not covered. The rating is calculated by assigning 10 points to each component marked as covered and dividing by the maximum number of components in that particular session (see the Multimedia Appendix 1). In the ACT Core Competency Rating Form, the rater evaluates the counselor’s competency in ACT on a scale of 1-7, from “never true” to “always true.” The supervisor provides written feedback based on the ratings of the rated sessions. Low treatment adherence is addressed by additional training and repeated assessment of adherence on additional cases. Treatment fidelity is attained when 85% or more (ie, ≥8) of the session components were covered and when receiving an overall rating of adequate or above adequate delivery (eg, ≥5) of the ACT essential components.

Follow-up Assessments and Treatment Evaluation

After the final health counseling session, participants attend 2 in-person follow-up visits, at 1-week and 1-month posttreatment, in which they complete a CO test as well as web-based questionnaires about tobacco use, depression, anxiety, and ACT-related constructs. At the 1-month visit, participants rate the degree of acceptability and helpfulness of each ACT component and their satisfaction with the PRESENT Wellness Program.

Financial Compensation

Participants are compensated in the form of gift cards for each of the in-person visits in which they complete assessments (ie, US $30 for baseline and 1 week after end of treatment; and US $40 for 1-month posttreatment follow-up). Thus, participants could receive a maximum total of US $100/person for the completion of assessments and health counseling sessions.

Measures

Primary Outcomes

The primary outcomes of the study are feasibility of recruitment, feasibility of retention, and treatment acceptability. The feasibility of recruitment will be measured by the proportion of participants who consented to participate and attended the baseline session out of the number of individuals who were eligible. The feasibility of retention will be measured by the number of health sessions completed and the rate of follow-up visit completion. Treatment acceptability will be measured by the Program Acceptability Questions (see the Multimedia Appendix 2), an investigator-developed questionnaire rating the degree of acceptability and helpfulness of the PRESENT Wellness Program. The questionnaire contains 7 items categorized on a 5-point Likert scale ranging from “Completely Disagree” to “Completely Agree.” Higher scores indicate higher acceptability. A sample item is “This program has helped in my acceptance of my physical cravings, emotions, and thoughts that cue my smoking.”

Secondary Outcomes
Smoking Abstinence

Seven-day point prevalence and continuous abstinence will be reported following the Society for Research on Nicotine and Tobacco guidelines [53,54]. Seven-day point prevalence abstinence is defined as a self-report of no smoking during the previous 7 days and a CO level of less than 6 ppm. Continuous abstinence is defined as a self-report of no smoking since the quit date and biochemically confirmed abstinence at all follow-ups up to and including that time point.

Probable Depression

Probable depression is measured by the Patient Health Questionnaire [49,50], which evaluates symptoms for the last 2 weeks. Items range from not at all (0) to nearly every day (3). The scores for each item are summed to produce a total score between 0 and 24 points. Higher scores indicate higher depressive symptoms. Probable depression is determined by a total score of 10 or above, indicating at least moderate symptoms [50].

Probable Anxiety

Probable anxiety is measured by the Generalized Anxiety Disorder Scale [51], which evaluates symptoms for the last 2 weeks. Items range from not at all (0) to nearly every day (3). The scores for each item are summed to produce a total score between 0 and 21 points. Higher scores indicate higher anxiety symptoms. Probable anxiety is determined by a total score of 10 or above, indicating at least moderate symptoms [51].

Data Analyses

Data analyses in the context of a pilot study are not hypothesis-driven but serve to provide information regarding feasibility and acceptability of the intervention [55]. As such, data analyses will include descriptive statistics (eg, mean tests and proportions) about screening, recruitment, retention, process assessments, and treatment acceptability. We will use descriptive analysis techniques to present participants’ characteristics, as well as their scores on secondary outcome measures at the 3 different time points (baseline, 1 week after end of treatment, and 1-month posttreatment).

Ethics Approval

The first author and principal investigator of the study received institutional review board approval from her academic institution, the University of Houston (#00001007).


The outputs of the intervention development (phase 1) were (1) a treatment manual, which guided the health counselors’ training, and (2) the participant’s guide. Recruitment was completed in 2021. After project implementation and data management and analyses are conducted, the outcomes of the pilot study (phase 2) will be published in a separate paper. Dissemination of outcomes from phase 2 is slated for May 2023.


Despite the availability of evidence-based interventions for smoking cessation, there is still a need for interventions focused on individuals with behavioral health challenges, given their high smoking rate and difficulty quitting. Similarly, culturally appropriate interventions for the Latine community, the largest ethnic group in the United States, are greatly needed. To address these gaps, the innovation of the PRESENT Wellness Program lies in the adaptation and testing of an ACT smoking cessation intervention for Latine smokers with clinically significant depression and anxiety symptomatology. This entails refinements and new applications of an existing theoretical and evidence-based clinical approach (ie, ACT) for understudied comorbid conditions (ie, depression, anxiety, and smoking) among an underserved and understudied ethnic minority group (ie, Latine). Besides adaptations in content, the proposed protocol is delivered in a hybrid format, with 1 session in person and the rest by phone, which is expected to address common treatment barriers for Latine individuals (eg, childcare and transportation). All these aspects are strengths of the study.

The implementation of the PRESENT Wellness Program will provide data on the feasibility and acceptability of the intervention as well as preliminary data on the impact of the intervention on decreasing smoking, anxiety and depression, and addressing ACT-related constructs. As primary outcomes, it is expected that recruitment and retention into the intervention is feasible and that the provided treatment is acceptable. For secondary outcomes, it is expected that there is an increase in participants’ smoking abstinence and a decrease in depression and anxiety symptoms at the end of treatment and 1-month posttreatment. Our findings will help inform large-scale ACT-based smoking cessation studies for Latine adults with psychological distress and may contribute to a growing body of evidence of the importance of culturally relevant interventions. Findings will be disseminated via professional forums as well as community-accessible venues, such as our laboratory website, social media, and newsletters.

Of note, this pilot study was focused on English-speaking Latine individuals mainly for pragmatic reasons related to study budget and the feasibility of conducting the intervention and related supervision in only one language. Nonetheless, we acknowledge this is a limitation as excluding Spanish-preferring individuals will reduce the generalizability of findings and the reach of the intervention. We believe there is an urgency to reach Spanish-speaking Latine individuals who smoke and, as such, will work on the translation and linguistic adaptation of the intervention as a next step in this line of research.

Acknowledgments

This pilot and feasibility study is supported by a Mentored Research Scholar Grant in Applied and Clinical Research from the American Cancer Society awarded to the first author (MRSG-15-018-01-CPPB). We are appreciative of Mirna Centeno, from the Health Research Institute, for her graphic designer work while assisting in the development of recruitment materials. Authors are also grateful for the Scholarly Publication Grant of the University of Houston’s Underrepresented Women of Color Coalition.

Data Availability

Data sharing is not applicable to this research protocol paper as no clean data sets have been generated for data management or analyses in this study.

Conflicts of Interest

None declared.

Multimedia Appendix 1

Treatment Fidelity: Checklist Sample.

DOCX File , 15 KB

Multimedia Appendix 2

Program Acceptability Questions.

DOCX File , 14 KB

  1. Ries LG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER cancer statistics review, 1975-2001. National Cancer Institute. 2004. URL: https://seer.cancer.gov/archive/csr/1975_2001/ [accessed 2023-02-18]
  2. WHO report on the global tobacco epidemic 2019. World Health Organization. 2019. URL: https:/​/www.​who.int/​teams/​health-promotion/​tobacco-control/​who-report-on-the-global-tobacco-epidemic-2019 [accessed 2023-02-17]
  3. Rojas G, Gaete J, González I, Ortega M, Figueroa A, Fritsch R, et al. [Tobacco smoking and mental health]. Rev Med Chil. 2003;131(8):873-880. [Medline]
  4. Goodwin RD, Zvolensky MJ, Keyes KM, Hasin DS. Mental disorders and cigarette use among adults in the United States. Am J Addict. 2012;21(5):416-423. [FREE Full text] [CrossRef] [Medline]
  5. Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009;9:285. [FREE Full text] [CrossRef] [Medline]
  6. Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008;10(12):1691-1715. [CrossRef] [Medline]
  7. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284(20):2606-2610. [CrossRef] [Medline]
  8. Glassman AH. Cigarette smoking and its comorbidity. NIDA Res Monogr. 1997;172:52-60. [Medline]
  9. Burgess ES, Brown RA, Kahler CW, Niaura R, Abrams DB, Goldstein MG, et al. Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse? J Consult Clin Psychol. 2002;70(2):356-361. [FREE Full text] [CrossRef] [Medline]
  10. Kahler CW, Brown RA, Ramsey SE, Niaura R, Abrams DB, Goldstein MG, et al. Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. J Abnorm Psychol. 2002;111(4):670-675. [CrossRef] [Medline]
  11. Piper ME, Smith SS, Schlam TR, Fleming MF, Bittrich AA, Brown JL, et al. Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol. 2010;78(1):13-23. [FREE Full text] [CrossRef] [Medline]
  12. Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Addiction. 2011;106(2):418-427. [FREE Full text] [CrossRef] [Medline]
  13. Blalock JA, Robinson JD, Wetter DW, Cinciripini PM. Relationship of DSM-IV-based depressive disorders to smoking cessation and smoking reduction in pregnant smokers. Am J Addict. 2006;15(4):268-277. [CrossRef] [Medline]
  14. Zvolensky MJ, Gibson LE, Vujanovic AA, Gregor K, Bernstein A, Kahler C, et al. Impact of posttraumatic stress disorder on early smoking lapse and relapse during a self-guided quit attempt among community-recruited daily smokers. Nicotine Tob Res. 2008;10(8):1415-1427. [CrossRef] [Medline]
  15. Morissette SB, Tull MT, Gulliver SB, Kamholz BW, Zimering RT. Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychol Bull. 2007;133(2):245-272. [CrossRef] [Medline]
  16. Zvolensky MJ, Stewart SH, Vujanovic AA, Gavric D, Steeves D. Anxiety sensitivity and anxiety and depressive symptoms in the prediction of early smoking lapse and relapse during smoking cessation treatment. Nicotine Tob Res. 2009;11(3):323-331. [FREE Full text] [CrossRef] [Medline]
  17. Hitsman B, Borrelli B, McChargue DE, Spring B, Niaura R. History of depression and smoking cessation outcome: a meta-analysis. J Consult Clin Psychol. 2003;71(4):657-663. [CrossRef] [Medline]
  18. Japuntich SJ, Smith SS, Jorenby DE, Piper ME, Fiore MC, Baker TB. Depression predicts smoking early but not late in a quit attempt. Nicotine Tob Res. 2007;9(6):677-686. [CrossRef] [Medline]
  19. Watson D. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. J Abnorm Psychol. 2005;114(4):522-536. [CrossRef] [Medline]
  20. Mykletun A, Overland S, Aarø LE, Liabø HM, Stewart R. Smoking in relation to anxiety and depression: evidence from a large population survey: the HUNT study. Eur Psychiatry. 2008;23(2):77-84. [CrossRef] [Medline]
  21. Correa-Fernández V, Ji L, Castro Y, Heppner WL, Vidrine JI, Costello TJ, et al. Mediators of the association of major depressive syndrome and anxiety syndrome with postpartum smoking relapse. J Consult Clin Psychol. 2012;80(4):636-648. [FREE Full text] [CrossRef] [Medline]
  22. Fiore M, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD. U.S. Dept. of Health and Human Services, Public Health Service; 2008.
  23. Twohig MP. Introduction: the basics of acceptance and commitment therapy. Cogn Behav Pract. 2012;19(4):499-507. [FREE Full text]
  24. Hayes SC, Barnes-Holmes D, Roche B. Relational Frame Theory: A Post-Skinnerian Account of Human Language and Cognition. New York. Plenum Press; 2001.
  25. Blackledge JT, Hayes SC. Emotion regulation in acceptance and commitment therapy. J Clin Psychol. 2001;57(2):243-255. [CrossRef] [Medline]
  26. Clark DM, Ball S, Pape D. An experimental investigation of thought suppression. Behav Res Ther. 1991;29(3):253-257. [CrossRef] [Medline]
  27. Marlatt GA, Gordon JR. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York. The Guilford Press; 1985.
  28. Gifford EV, Kohlenberg BS, Hayes SC, Pierson HM, Piasecki MP, Antonuccio DO, et al. Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes?: a randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation. Behav Ther. 2011;42(4):700-715. [CrossRef] [Medline]
  29. Arch JJ, Wolitzky-Taylor KB, Eifert GH, Craske MG. Longitudinal treatment mediation of traditional cognitive behavioral therapy and acceptance and commitment therapy for anxiety disorders. Behav Res Ther. 2012;50(7-8):469-478. [CrossRef] [Medline]
  30. O'Connor M, Whelan R, Bricker J, McHugh L. Randomized controlled trial of a smartphone application as an adjunct to acceptance and commitment therapy for smoking cessation. Behav Ther. 2020;51(1):162-177. [CrossRef] [Medline]
  31. Bricker JB, Watson NL, Mull KE, Sullivan BM, Heffner JL. Efficacy controlled trial of a smartphone application as an adjunct to acceptance and commitment therapy for smoking cessation. JAMA Intern Med. 2020;180(11):1472-1480. [FREE Full text] [CrossRef] [Medline]
  32. Masuda A. Mindfulness & Acceptance in Multicultural Competency. Oakland, California. New Harbinger Publications; 2014.
  33. Colby SL, Ortman JM. Population estimates and projections. In: Projections of the Size and Composition of The US Population: 2014 to 2060. Washington, DC. CQ Press; 2017.
  34. State and county quick facts. U.S. Census Bureau. 2014. URL: http://quickfacts.census.gov/qfd/states/00000.html [accessed 2014-10-01]
  35. Gregg JA, Callaghan GM, Hayes SC, Glenn-Lawson JL. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial. J Consult Clin Psychol. 2007;75(2):336-343. [CrossRef] [Medline]
  36. Kwon DM, Santiago-Torres M, Mull KE, Sullivan BM, Zvolensky MJ, Bricker JB. Web-delivered acceptance and commitment therapy (ACT) for smoking cessation: is it engaging and efficacious for US Hispanic/Latinx adult smokers? Prev Med Rep. 2022;29:101952. [FREE Full text] [CrossRef] [Medline]
  37. Luoma JB, Hayes SC, Walser RD. Learning ACT: An Acceptance and Commitment Therapy Skills-Training Manual for Therapists. 2nd ed. Oakland, CA. New Harbinger Publications; 2017.
  38. Bricker JB, Mull KE, Kientz JA, Vilardaga R, Mercer LD, Akioka KJ, et al. Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy. Drug Alcohol Depend. 2014;143:87-94. [FREE Full text] [CrossRef] [Medline]
  39. Gifford EV, Kohlenberg BS, Hayes SC, Antonuccio DO, Piasecki MM, Rasmussen-Hall ML, et al. Acceptance-based treatment for smoking cessation. Behav Ther. 2004;35(4):689-705. [CrossRef]
  40. Mak YW, Loke AY. The acceptance and commitment therapy for smoking cessation in the primary health care setting: a study protocol. BMC Public Health. 2015;15:105. [FREE Full text] [CrossRef] [Medline]
  41. Resnicow K, Baranowski T, Ahluwalia JS, Braithwaite RL. Cultural sensitivity in public health: defined and demystified. Ethn Dis. 1999;9(1):10-21. [Medline]
  42. Resnicow KR, Soler R, Braithwaite R, Ahluwalia JS, Butler J. Cultural sensitivity in substance use prevention. J Community Psychol. 2000;28(3):271-290. [FREE Full text] [CrossRef]
  43. Benuto L, Leany BD. Reforms for ethnic minorities and women. In: Cummings NA, O'Donohue WT, editors. Understanding the Behavioral Healthcare Crisis: The Promise of Integrated Care and Diagnostic Reform. New York. Routledge; 2011.
  44. Carrillo JE, Green AR, Betancourt JR. Cross-cultural primary care: a patient-based approach. Ann Intern Med. 1999;130(10):829-834. [CrossRef] [Medline]
  45. Green AR, Betancourt JR, Carrillo JE. Integrating social factors into cross-cultural medical education. Acad Med. 2002;77(3):193-197. [CrossRef] [Medline]
  46. Webb MS, Rodríguez-Esquivel D, Baker EA. Smoking cessation interventions among Hispanics in the United States: a systematic review and mini meta-analysis. Am J Health Promot. 2010;25(2):109-118. [CrossRef] [Medline]
  47. Stoddard JA, Afari N. The Big Book of ACT Metaphors: A Practitioner's Guide to Experiential Exercises and Metaphors in Acceptance and Commitment Therapy. Oakland, CA. New Harbinger Publications; 2014.
  48. Gierisch JM, Bastian LA, Calhoun PS, McDuffie JR, Williams JWJ. Comparative Effectiveness of Smoking Cessation Treatments for Patients With Depression. Washington (DC). Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service,; 2010.
  49. Dhingra SS, Kroenke K, Zack MM, Strine TW, Balluz LS. PHQ-8 days: a measurement option for DSM-5 major depressive disorder (MDD) severity. Popul Health Metr. 2011;9:11. [FREE Full text] [CrossRef] [Medline]
  50. Kroenke K, Strine TW, Spitzer RL, Williams JBW, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1-3):163-173. [CrossRef] [Medline]
  51. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. [CrossRef] [Medline]
  52. ResearchMatch. URL: https://www.researchmatch.org/ [accessed 2023-02-15]
  53. Hughes JR, Benowitz N, Hatsukami D, Mermelstein RJ, Shiffman S. Clarification of SRNT workgroup guidelines for measures in clinical trials of smoking cessation therapies. Nicotine Tob Res. 2004;6(5):863-864. [CrossRef] [Medline]
  54. Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P, Jarvis MJ, et al. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tob Res. 2020;22(7):1086-1097. [FREE Full text] [CrossRef] [Medline]
  55. Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2011;45(5):626-629. [FREE Full text] [CrossRef] [Medline]


ACT: acceptance and commitment therapy
CO: carbon monoxide
NRT: nicotine replacement therapy
SMART: specific, meaningful, adaptive, realistic, and timebound


Edited by T Leung; The proposal for this study was peer reviewed by the Mentored Research Scholar Grant in Applied and Clinical Research - American Cancer Society (Atlanta, Georgia, USA). submitted 08.11.22; accepted 24.01.23; published 04.04.23.

Copyright

©Virmarie Correa-Fernández, Janice A Blalock, Megan E Piper, Glorisa Canino, David W Wetter. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 04.04.2023.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.